Because the aforementioned results are somewhat descriptive, we encourage further experimental studies to obtain better mechanistic insights into the potentially relevant interactions of LGALS9 and CD44 in the context of inflammatory vascular diseases such as AAA. This evidence concerns the gene CD44 and triple-A syndrome.